These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15573304)

  • 1. [Familial multiple sclerosis in Canary Islands].
    Amela-Peris R; Aladro Y; Conde-Sendín MA; Alemany-Rodríguez MJ; Muñoz-Fernández C; Reyes-Yáñez MP; Déniz-Naranjo MC; Sánchez-García F
    Rev Neurol; 2004 Nov 16-30; 39(10):911-4. PubMed ID: 15573304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
    J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Familial multiple sclerosis: a study of six families].
    Landete L; Casanova B; Burguera JA
    Rev Neurol; 1998 Jul; 27(155):43-7. PubMed ID: 9674023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial effects on the clinical course of multiple sclerosis.
    Hensiek AE; Seaman SR; Barcellos LF; Oturai A; Eraksoi M; Cocco E; Vecsei L; Stewart G; Dubois B; Bellman-Strobl J; Leone M; Andersen O; Bencsik K; Booth D; Celius EG; Harbo HF; Hauser SL; Heard R; Hillert J; Myhr KM; Marrosu MG; Oksenberg JR; Rajda C; Sawcer SJ; Sørensen PS; Zipp F; Compston DA
    Neurology; 2007 Jan; 68(5):376-83. PubMed ID: 17261686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relation between the HLA-DRB1*1501 allele and the severity of multiple sclerosis in a sample of the Spanish population from the Balearic Islands: the influence exerted by sex].
    Zabay-Becerril JM; Burcet-Dardé J; Mulet-Ferrer J; Soler-Farré J; Viader-Farré C
    Rev Neurol; 2004 Jan 16-31; 38(2):118-22. PubMed ID: 14752708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features of familial multiple sclerosis in Spain].
    Fernández-Pérez MJ; Barakat O; García-Moreno JM; Lucas M; Navarro G; Gata JM; Gamero MA; Duque P; Izquierdo G
    Rev Neurol; 1999 Oct 16-31; 29(8):693-6. PubMed ID: 10560101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
    Chao MJ; Ramagopalan SV; Herrera BM; Lincoln MR; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2009 Jan; 18(2):261-6. PubMed ID: 19098025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
    Stankovich J; Butzkueven H; Marriott M; Chapman C; Tubridy N; Tait BD; Varney MD; Taylor BV; Foote SJ; ; Kilpatrick TJ; Rubio JP
    Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The occurrence of autoimmune diseases in patients with multiple sclerosis and their families.
    Henderson RD; Bain CJ; Pender MP
    J Clin Neurosci; 2000 Sep; 7(5):434-7. PubMed ID: 10942666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of HLA-DRB1 and -DPB1 allele polymorphism with multiple sclerosis in Chinese Han population from Southern areas].
    Wu XM; Zhang KN; Wang CD; Xiong YQ; Liu Z; Qu XH; Xie XF
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2741-4. PubMed ID: 18167262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR15 is associated with lower age at onset in multiple sclerosis.
    Masterman T; Ligers A; Olsson T; Andersson M; Olerup O; Hillert J
    Ann Neurol; 2000 Aug; 48(2):211-9. PubMed ID: 10939572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami.
    Harbo HF; Utsi E; Lorentzen AR; Kampman MT; Celius EG; Myhr KM; Lie BA; Mellgren SI; Thorsby E
    Tissue Antigens; 2007 Apr; 69(4):299-304. PubMed ID: 17389012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DRB1 and multiple sclerosis in Malta.
    Dean G; Yeo TW; Goris A; Taylor CJ; Goodman RS; Elian M; Galea-Debono A; Aquilina A; Felice A; Vella M; Sawcer S; Compston DA
    Neurology; 2008 Jan; 70(2):101-5. PubMed ID: 18057318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis.
    Cournu-Rebeix I; Génin E; Leray E; Babron MC; Cohen J; Gout C; Alizadeh M; Perdry H; Semana G; Brassat D; Clerget-Darpoux F; Yaouanq J; Edan G; Rosenheim M; Fontaine B
    Genes Immun; 2008 Sep; 9(6):570-4. PubMed ID: 18615093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of multiple sclerosis in the Canary Islands (Spain): a study on the island of La Palma.
    Hernández MA
    J Neurol; 2002 Oct; 249(10):1378-81. PubMed ID: 12382152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
    Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients.
    Lorentzen AR; Celius EG; Ekstrøm PO; Wiencke K; Lie BA; Myhr KM; Ling V; Thorsby E; Vartdal F; Spurkland A; Harbo HF
    J Neuroimmunol; 2005 Sep; 166(1-2):197-201. PubMed ID: 16005527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal - offspring HLA-DRB1 compatibility in multiple sclerosis.
    Willer CJ; Dyment DA; Sadovnick AD; Ebers GC
    Tissue Antigens; 2005 Jul; 66(1):44-7. PubMed ID: 15982256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis.
    Callander M; Haghighi S; Landtblom AM; Ahlgren CE; Nilsson SI; Rydberg L; Al Khoury H; Rosegren L; Andersen O
    Mult Scler; 2007 May; 13(4):441-5. PubMed ID: 17463066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HLA locus and multiple sclerosis in Sicily.
    Brassat D; Salemi G; Barcellos LF; McNeill G; Proia P; Hauser SL; Oksenberg JR; Savettieri G
    Neurology; 2005 Jan; 64(2):361-3. PubMed ID: 15668443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.